Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BERG DT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stone, RM; Berg, DT; George, SL; Dodge, RK; Paciucci, PA; Schulman, PP; Lee, EJ; Moore, JO; Powell, BL; Baer, MR; Bloomfield, CD; Schiffer, CA
      Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

      BLOOD
    2. Richardson, MA; Berg, DT; Calnek, DS; Ciaccia, AV; Joyce, DE; Grinnell, BW
      17 beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway

      ENDOCRINOLOGY
    3. Engelking, C; Sauerland, C; Rychcik, J; Hill, GJ; Berg, DT; Lilienfeld, C
      Colorectal cancer in a 43-year-old man

      CANCER PRACTICE
    4. JACKSON GV; SHETLER TJ; BALLEY BD; GERLITZ BE; BERG DT; GRINNELL BW
      RECOMBINANT, WOMAN, ACTIVATED PROTEIN-C (LY203638)-INDUCED REPERFUSION IN A CANINE MODEL OF OCCLUSIVE CORONARY-ARTERY THROMBOSIS

      Circulation
    5. RICHARDSON MA; BERG DT; COX DA; GRINNELL BW
      RALOXIFENE REGULATES THROMBOMODULIN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN HUMAN ENDOTHELIAL-CELLS

      Circulation
    6. BLOOMFIELD CD; LAWRENCE D; BYRD JC; CARROLL A; PETTENATI MJ; TANTRAVAHI R; PATIL SR; DAVEY FR; BERG DT; SCHIFFER CA; ARTHUR DC; MAYER RJ
      FREQUENCY OF PROLONGED REMISSION DURATION AFTER HIGH-DOSE CYTARABINE INTENSIFICATION IN ACUTE MYELOID-LEUKEMIA VARIES BY CYTOGENETIC SUBTYPE

      Cancer research
    7. STONE RM; BERG DT; GEORGE SL; DODGE RK; PACIUCCI PA; SCHULMAN P; LEE EJ; MOORE JO; POWELL BL; SCHIFFER CA
      POST REMISSION THERAPY IN OLDER PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - A RANDOMIZED TRIAL OF MITOXANTRONE INTERMEDIATE DOSE CYTARABINE-V STANDARD-DOSE CYTARABINE (CALBG-8923)/

      Blood
    8. GRINNELL BW; BERG DT
      SURFACE THROMBOMODULIN MODULATES THROMBIN RECEPTOR RESPONSES ON VASCULAR SMOOTH-MUSCLE CELLS

      American journal of physiology. Heart and circulatory physiology
    9. BERG DT; WILEY MR; GRINNELL BW
      ENHANCED PROTEIN-C ACTIVATION AND INHIBITION OF FIBRINOGEN CLEAVAGE BY A THROMBIN MODULATOR

      Science
    10. RICHARDSON MA; BERG DT; JOHNSTON PA; MCCLURE D; GRINNELL BW
      HUMAN LIPOSARCOMA CELL-LINE, SW872, SECRETES CHOLESTERYL ESTER TRANSFER PROTEIN IN RESPONSE TO CHOLESTEROL

      Journal of lipid research
    11. BERG DT; CALNEK DS; GRINNELL BW
      TRANS-REPRESSOR BEF-1 PHOSPHORYLATION - A POTENTIAL CONTROL MECHANISMFOR HUMAN APOE GENE-REGULATION

      The Journal of biological chemistry
    12. MAYER RJ; DAVIS RB; BERG DT
      POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - REPLY

      The New England journal of medicine
    13. STONE RM; BERG DT; GEORGE SL; DODGE RK; PACIUCCI PA; SCHULMAN P; LEE EJ; MOORE JO; POWELL BL; SCHIFFER CA
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER INITIAL CHEMOTHERAPY FOR ELDERLY PATIENTS WITH PRIMARY ACUTE MYELOGENOUS LEUKEMIA

      The New England journal of medicine
    14. BERG DT; CALNEK DS; GRINNELL BW
      THE HUMAN APOLIPOPROTEIN-E GENE IS NEGATIVELY REGULATED IN HUMAN LIVER HEPG2 CELLS BY THE TRANSCRIPTION FACTOR BEF-1

      The Journal of biological chemistry
    15. STONE RM; PIRO ID; SAVEN A; BERG DT; BRYAN WJ; FAY JW; HERZIG GP; HERZIG RH; SHIELDS AF; COLEMAN BS; LEE EJ
      A PHASE-I NOVEL ALKYLATING AGENT (AA), ADOZELESIN PATIENTS (PTS) WITHREFRACTORY HEMATOLOGIC MALIGNANCIES (HM)

      Blood
    16. GRINNELL BW; GERLITZ B; BERG DT
      IDENTIFICATION OF A REGION IN PROTEIN-C INVOLVED IN THROMBOMODULIN-STIMULATED ACTIVATION BY THROMBIN - POTENTIAL REPULSION AT ANION-BINDINGSITE-I IN THROMBIN

      Biochemical journal
    17. MAYER RJ; DAVIS RB; SCHIFFER CA; BERG DT; POWELL BL; SCHULMAN P; OMURA GA; MOORE JO; MCINTYRE OR; FREI E
      INTENSIVE POSTREMISSION CHEMOTHERAPY IN ADULTS WITH ACUTE MYELOID-LEUKEMIA

      The New England journal of medicine
    18. BLOOMFIELD CD; LAWRENCE D; ARTHUR DC; BERG DT; SCHIFFER CA; MAYER RJ
      CURATIVE IMPACT OF INTENSIFICATION WITH HIGH-DOSE CYTARABINE (HIDAC) IN ACUTE MYELOID-LEUKEMIA (AML) VARIES BY CYTOGENETIC GROUP

      Blood
    19. BERG DT; MCCLURE DB; GRINNELL BW
      HIGH-LEVEL EXPRESSION OF SECRETED PROTEINS FROM CELLS ADAPTED TO SERUM-FREE SUSPENSION-CULTURE

      BioTechniques
    20. STONE RM; TORIGOE PS; BERG DT; MIZOBUCHI T; MAYER RJ; CANNISTRA SA
      INTERLEUKIN-3 (IL-3) BEFORE AND DURING INTERMITTENT CONTINUOUS-INFUSION HIGH-DOSE ARA-C (ICHDAC) THERAPY FOR REFRACTORY OR SECONDARY ACUTE MYELOID-LEUKEMIA (AML)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 09:11:43